PressDigest

J&J closes in on Pharmacyclics takeover

Johnson & Johnson is learnt to be in advanced discussions to buy US cancer drugmaker Pharmacyclics, in a potential blockbuster deal that would mark the latest chapter in the ongoing consolidation of the global healthcare industry.

WSJ Logo
Ray Dalio Sells Last Stake in Bridgewater, the Hedge Fund That Made Him a BillionaireExternal link

Ray Dalio Sells Last Stake in Bridgewater, the Hedge Fund That Made Him a Billionaire